Skip to main content
Clinical Trials/JPRN-UMIN000012210
JPRN-UMIN000012210
Completed
未知

Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy. - Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy.

Kurume University Hospital0 sites10 target enrollmentNovember 5, 2013
ConditionsBreast cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Kurume University Hospital
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 5, 2013
End Date
October 31, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Physician judged improper to entry this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials